Global Sulfasalazine Market Research Report 2020

Sulfasalazine is a sulfanilamide antibiotic.It is an oral sulfonamide drug that is not easy to be absorbed. The absorbed part is decomposed into 5-amino salicylic acid and sulfonamide pyridine under the action of intestinal microorganisms.5-aminosalicylic acid stays in the intestinal wall for a long time after complexing with the connective tissue of the intestinal wall, which plays an antibacterial and anti-inflammatory role and plays an immunosuppressive role, such as reducing escherichia coli and clostridium difficile, and inhibiting the synthesis of prostaglanin and other inflammatory mediators, leukotrienes.Therefore, it is believed that the main component of this product is 5-aminosalicylic acid.Sulfamopyridine produced by the decomposition of this product showed weak antibacterial effect on intestinal flora.

The global Sulfasalazine market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Sulfasalazine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Sulfasalazine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Sulfasalazine market is segmented into
Enteric Sugar Coated Tablet
Film-Coated Tablet
Other

Segment by Application
Crohn's Disease
Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
Ankylosing Spondylitis
Other

Global Sulfasalazine Market: Regional Analysis
The Sulfasalazine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Sulfasalazine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Sulfasalazine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Sulfasalazine market include:
Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical